Regulus Therapeutics

-$0.0233 (-10.25%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can watch RGLS and buy or sell other stocks, options, and ETFs commission-free!

About RGLS

Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development.

CEO
Joseph P. Hagan
Employees
26
Headquarters
San Diego, California
Founded
2007

RGLS Key Statistics

Market cap
29.78M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.25M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$0.8724
52 Week low
$0.1576
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure